See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2018_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,953,900,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,991,800,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,325,400,000 |
| 3 | remainder_Assets | 312,200,000 |
| 4 | LiabilitiesCurrent | 952,500,000 |
| 5 | LiabilitiesNoncurrent | 2,860,900,000 |
| 6 | remainder_Liabilities | 876,800,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,274,181,428 |
| 9 | ResearchAndDevelopmentExpense | 1,147,424,575 |
| 10 | remainder_Expenses | 1,396,436,846 |
| 11 | remainder_Revenues | 4,515,180,493 |
| 12 | remainder_NetIncome | 13,613,611 |
| 13 | remainder_ComprehensiveNetIncome | -59,573,187 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,583,300,000 |
| 1 | Liabilities | 4,690,200,000 |
| 2 | Expenses | 3,818,042,849 |
| 3 | Revenues | 4,515,180,493 |
| 4 | StockholdersEquity | 8,893,100,000 |
| 5 | NetIncome | 710,751,255 |
| 6 | ComprehensiveNetIncome | 680,964,662 |
| 7 | BaseVar | 13,339,955,070 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.20 |
| 9 | EconomicCapitalRatio | 3.16 |
Edgar->Model Mapping
Feature Distribution
Change over Time
